Palliative Radiotherapy Given Concurrently or Within 4 Weeks of Initiation of Immunotherapy is Associated with Sustained Clinical Response to Immune Checkpoint Inhibitors in Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC)
Published in
International Journal of Radiation Oncology, Biology, Physics, September 2019
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 September 2019.
All research outputs
#31,228,352
of 34,411,289 outputs
Outputs from International Journal of Radiation Oncology, Biology, Physics
#13,973
of 15,467 outputs
Outputs of similar age
#336,489
of 378,158 outputs
Outputs of similar age from International Journal of Radiation Oncology, Biology, Physics
#191
of 257 outputs
Altmetric has tracked 34,411,289 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 15,467 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 378,158 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 257 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
